NEW YORK – Genomic testing startup GeneMe is channeling enhanced isothermal molecular diagnostic technologies into point-of-care tests for COVID-19. The Gdansk, Poland-based company claims its extraction-free loop-mediated isothermal amplification (LAMP) test has a limit of detection of 20 viral copies per milliliter, placing it among the most sensitive molecular assays in the world.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.